Imaging Biomarker Core
Imaging Biomarker Core
批准号:
10662489
负责人:
EMILY J ROGALSKI
金额:
$78.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-15 至 2026-06-30
关键词:
AchievementAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyBiological MarkersBiomedical EngineeringClinicalCognitiveCollaborationsDataData SetDatabasesDedicationsDementiaDiagnosticDifferential DiagnosisDiscipline of Nuclear MedicineEligibility DeterminationEnsureExtramural ActivitiesFunctional ImagingFundingFutureGoalsHeterogeneityHigh Performance ComputingHospitalsImageImpaired cognitionIndividualInfrastructureInstitutionMagnetic Resonance ImagingMethodsMissionNational Institute of Neurological Disorders and StrokeNational Institute on Deafness and Other Communication DisordersNatural HistoryOutputPET/CT scanParticipantPhasePhenotypePositron-Emission TomographyProcessRadiology SpecialtyRecordsResearchResearch PersonnelResearch Project GrantsResourcesRunningScanningStructureTranslational ResearchUniversitiesamnestic mild cognitive impairmentcluster computingcohortdata archivedata integrationdata managementfallsimage translationimaging biomarkerimaging modalityimprovedmolecular imagingmultimodal neuroimagingneuroimagingquality assurancerecruitstatisticsstructural imagingtooltraining opportunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - IMAGING BIOMARKER CORE
The Northwestern ADRC Imaging Biomarker Core has the long-term goal to characterize all eligible Clinical
Core participants with state-of-the-art structural, functional, and molecular imaging and curate these data for
use in future projects. The Northwestern ADRC Clinical Core currently maintains a cohort of over 500
participants. Approximately half of the Clinical Core Participants receive systematic MR imaging funded by
R01s from NIA, NINDS, and NIDCD. During the last cycle, the Imaging Biomarker Core increased imaging
coverage from approximately 50% of the Clinical Core cohort to nearly 70%. For the next cycle, it will acquire
and process structural, functional, and molecular imaging on additional Clinical Core participants who are not
covered by other research grants and who are targeted for relevant collaborative studies. We will use
advanced acquisition and analysis methods and ensure these data are integrated with other variables within an
infrastructure that supports intramural and extramural collaborations and provides rich opportunities for
training. The Imaging Biomarker Core is highly interconnected with the other Northwestern ADRC Cores in a
manner that enhances the missions of NAPA and the NIA. It will be guided by the following goals:
1) Acquire systematic and multimodal neuroimaging (MR, PET) on Clinical Core participants who lack these
biomarkers and who are eligible/recruited for collaborative studies we support. To this end, Clinical Core
participants including cognitively healthy controls, individuals with amnestic mild cognitive impairment
(aMCI), and individuals with AD/ADRD will be scanned with advanced PET and MR imaging modalities.
2) Curate and share integrated imaging datasets on Clinical Core participants, which will serve intramural
and extramural collaborations including REC trainee projects. This aim will draw upon a mature institutional
computing structure to run pipelines for quality assurance, processing, and analysis of imaging data. The
resulting imaging outputs will be incorporated with clinical and post-mortem data in our unified ADRC
NeuroFiles database developed in collaboration with the Data Management and Statistics Core.
The infrastructure of the Imaging Biomarker Core includes two research-dedicated 3T Siemens MR magnets at
Northwestern’s Center for Translational Imaging (CTI) and a PET/CT scanner at Northwestern Memorial
Hospital. Data are directly routed from the scan console to the Northwestern University Neuroimaging Data
Archive (NUNDA), where quality assurance and analysis tools are launched with the support of a high-
performance computing cluster called QUEST. Collectively, these data will enhance the clinical and diagnostic
characterization of each Clinical Core participant and will be made available to approved intramural and
national collaborators including NACC. All phases of this proposal will offer unique opportunities for the training
of junior investigators in areas related to imaging and translational research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative/Biostatistics Core
-
批准号:10276526
-
项目类别:
-
资助金额:$78.77万
-
财政年份:2021
-
负责人:EMILY J ROGALSKI
-
依托单位:
Administrative/Biostatistics Core
-
批准号:10687272
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2021
-
负责人:EMILY J ROGALSKI
-
依托单位:
Imaging Biomarker Core
-
批准号:10264373
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2021
-
负责人:EMILY J ROGALSKI
-
依托单位:
Imaging Biomarker Core
-
批准号:10469452
-
项目类别:
-
资助金额:$77.81万
-
财政年份:2021
-
负责人:EMILY J ROGALSKI
-
依托单位:
Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia
-
批准号:10674605
-
项目类别:
-
资助金额:$218.48万
-
财政年份:2017
-
负责人:EMILY J ROGALSKI
-
依托单位:
Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia
-
批准号:9890992
-
项目类别:
-
资助金额:$98.64万
-
财政年份:2017
-
负责人:EMILY J ROGALSKI
-
依托单位:
Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia
-
批准号:9449181
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2017
-
负责人:EMILY J ROGALSKI
-
依托单位:
Administrative Supplement to Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia
-
批准号:10058122
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2017
-
负责人:EMILY J ROGALSKI
-
依托单位:
Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia
-
批准号:10656037
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
-
批准号:9656047
-
项目类别:
-
资助金额:$101.62万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:8443796
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:8811483
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:9052227
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:8594038
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
-
批准号:9930396
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
-
批准号:10377361
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
-
批准号:9308150
-
项目类别:
-
资助金额:$67.4万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:8287441
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease
-
批准号:10116238
-
项目类别:
-
资助金额:$88.64万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
Determinants of Neurodegenerative Decline in Primary Progressive Aphasia
-
批准号:8625348
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2012
-
负责人:EMILY J ROGALSKI
-
依托单位:
海外基金